Abstract
Objective To investigate the impact of high circulating anti-M ul lerian hormone (AMH) on the outcome of ovulation induction using human menopausal gonadotropin (hMG)in women with polycystic ovary syndrome (PCOS). Methods This prospective study included 63 anovulatory women with PCOS who underwent hMG ovarian stimulation. Serum AMH concentrations were compared between responders and non-responders. The receiver-operating characteristic (ROC) curve was used to evaluate the prognostic value of circulating AMH. Results hMG responders had a significantly lower serum AMH concentration compared with non-responders (8.43±2.18 μ g/L vs 11.05±2.85 μ g/L , P g/L . Conclusion Serum AMH can be used as an effective parameter to predict ovarian response to hMG treatment in PCOS patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call